Your browser doesn't support javascript.
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.
Lee, Eudocia Q; Selig, Wendy; Meehan, Clair; Bacha, Jeffrey; Barone, Amy; Bloomquist, Erik; Chang, Susan M; de Groot, John F; Galanis, Evanthia; Hassan, Islam; Kalidas, Chitkala; Khasraw, Mustafa; Kvedar, Joseph C; Lassman, Andrew B; Puduvalli, Vinay; Sahebjam, Solmaz; Schwamm, Lee H; Tamir, Sharon; Welch, Mary; Yung, W K Alfred; Zadeh, Gelareh; Arons, David; Wen, Patrick Y.
  • Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Selig W; WSCollaborative, McLean, Virginia, USA.
  • Meehan C; National Brain Tumor Society, Newton, Massachusetts, USA.
  • Bacha J; Edison Oncology Holding Corp., Menlo Park, California, USA.
  • Barone A; Office of Hematology and Oncology Products at the Food and Drug Administration, Silver Spring, Maryland, USA.
  • Bloomquist E; Office of Biostatistics, Center for Drug Evaluation and Research at the Food and Drug Administration, Silver Spring, Maryland, USA.
  • Chang SM; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
  • de Groot JF; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Galanis E; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Hassan I; Agios Pharmaceuticals, Cambridge, Massachusetts, USA.
  • Kalidas C; Bayer Pharmaceuticals, Hillsborough, New Jersey, USA.
  • Khasraw M; Preston Robert Tisch Brain Tumor Center at Duke, Departments of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
  • Kvedar JC; Department of Dermatology at Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Lassman AB; Department of Neurology and Herbert Irving Comprehensive Cancer Center, New-York Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.
  • Puduvalli V; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sahebjam S; Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Schwamm LH; Department of Neurology at Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Tamir S; Karyopharm Therapeutics, Inc., Newton, Massachusetts, USA.
  • Welch M; Department of Neurology and Herbert Irving Comprehensive Cancer Center, New-York Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.
  • Yung WKA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zadeh G; MacFeeters-Hamilton Center for Neuro-Oncology, Princess Margaret Cancer Center, Toronto, Ontario, Canada.
  • Arons D; National Brain Tumor Society, Newton, Massachusetts, USA.
  • Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Neuro Oncol ; 23(8): 1252-1260, 2021 08 02.
Article in English | MEDLINE | ID: covidwho-1169684
ABSTRACT
On July 24, 2020, a workshop sponsored by the National Brain Tumor Society was held on innovating brain tumor clinical trials based on lessons learned from the COVID-19 experience. Various stakeholders from the brain tumor community participated including the US Food and Drug Administration (FDA), academic and community clinicians, researchers, industry, clinical research organizations, patients and patient advocates, and representatives from the Society for Neuro-Oncology and the National Cancer Institute. This report summarizes the workshop and proposes ways to incorporate lessons learned from COVID-19 to brain tumor clinical trials including the increased use of telemedicine and decentralized trial models as opportunities for practical innovation with potential long-term impact on clinical trial design and implementation.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Brain Neoplasms / COVID-19 Type of study: Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: North America Language: English Journal: Neuro Oncol Journal subject: Neoplasms / Neurology Year: 2021 Document Type: Article Affiliation country: Neuonc

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Brain Neoplasms / COVID-19 Type of study: Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: North America Language: English Journal: Neuro Oncol Journal subject: Neoplasms / Neurology Year: 2021 Document Type: Article Affiliation country: Neuonc